MetLife Investment Management’s V2X VVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $990K | Buy |
14,459
+1,678
| +13% | +$113K | 0.01% | 1398 |
|
|
2025
Q4 | $697K | Buy |
12,781
+1,491
| +13% | +$83.9K | ﹤0.01% | 1627 |
|
|
2025
Q3 | $656K | Buy |
11,290
+1,556
| +16% | +$83.2K | ﹤0.01% | 1682 |
|
|
2025
Q2 | $473K | Hold |
9,734
| – | – | ﹤0.01% | 1703 |
|
|
2025
Q1 | $477K | Buy |
9,734
+1,160
| +14% | +$56.9K | ﹤0.01% | 1752 |
|
|
2024
Q4 | $410K | Buy |
8,574
+1,534
| +22% | +$91K | ﹤0.01% | 1907 |
|
|
2024
Q3 | $393K | Hold |
7,040
| – | – | ﹤0.01% | 1913 |
|
|
2024
Q2 | $338K | Buy |
7,040
+933
| +15% | +$44.2K | ﹤0.01% | 1937 |
|
|
2024
Q1 | $285K | Hold |
6,107
| – | – | ﹤0.01% | 1982 |
|
|
2023
Q4 | $284K | Hold |
6,107
| – | – | ﹤0.01% | 2041 |
|
|
2023
Q3 | $315K | Hold |
6,107
| – | – | ﹤0.01% | 1911 |
|
|
2023
Q2 | $303K | Hold |
6,107
| – | – | ﹤0.01% | 2012 |
|
|
2023
Q1 | $243K | Hold |
6,107
| – | – | ﹤0.01% | 2102 |
|
|
2022
Q4 | $252K | Hold |
6,107
| – | – | ﹤0.01% | 2105 |
|
|
2022
Q3 | $216K | Hold |
6,107
| – | – | ﹤0.01% | 2252 |
|
|
2022
Q2 | $204K | Hold |
6,107
| – | – | ﹤0.01% | 2309 |
|
|
2022
Q1 | $219K | Buy |
6,107
+2,187
| +56% | +$93.4K | ﹤0.01% | 2307 |
|
|
2021
Q4 | $179K | Hold |
3,920
| – | – | ﹤0.01% | 2114 |
|
|
2021
Q3 | $197K | Sell |
3,920
-1,727
| -31% | -$81.6K | ﹤0.01% | 2112 |
|
|
2021
Q2 | $269K | Hold |
5,647
| – | – | ﹤0.01% | 1963 |
|
|
2021
Q1 | $302K | Hold |
5,647
| – | – | ﹤0.01% | 1809 |
|
|
2020
Q4 | $281K | Hold |
5,647
| – | – | ﹤0.01% | 1803 |
|
|
2020
Q3 | $215K | Hold |
5,647
| – | – | ﹤0.01% | 1823 |
|
|
2020
Q2 | $277K | Hold |
5,647
| – | – | ﹤0.01% | 1704 |
|
|
2020
Q1 | $234K | Hold |
5,647
| – | – | ﹤0.01% | 1607 |
|
|
2019
Q4 | $289K | Hold |
5,647
| – | – | ﹤0.01% | 1777 |
|
|
2019
Q3 | $230K | Hold |
5,647
| – | – | ﹤0.01% | 1869 |
|
|
2019
Q2 | $229K | Hold |
5,647
| – | – | ﹤0.01% | 1949 |
|
|
2019
Q1 | $150K | Hold |
5,647
| – | – | ﹤0.01% | 2141 |
|
|
2018
Q4 | $122K | Hold |
5,647
| – | – | ﹤0.01% | 2187 |
|
|
2018
Q3 | $176K | Hold |
5,647
| – | – | ﹤0.01% | 2154 |
|
|
2018
Q2 | $174K | Hold |
5,647
| – | – | ﹤0.01% | 1983 |
|
|
2018
Q1 | $210K | Hold |
5,647
| – | – | ﹤0.01% | 1860 |
|
|
2017
Q4 | $174K | Buy |
+5,647
| New | +$181K | ﹤0.01% | 2001 |
|
Other funds holding VVX
AL
RP
VCM
OAM
MetLife Investment Management's VVX Position: Q1 2026 in Review
MetLife Investment Management increased its V2X (VVX) stake by 13% in Q1 2026, buying an estimated $113K and bringing the position to 14,459 shares worth $990K. The position accounts for 0.01% of the portfolio, ranked #1398.
MetLife Investment Management first reported a position in VVX in Q4 2017 and has held it in 34 quarters since. 295 funds tracked by Wall St. Rank hold VVX as of Q1 2026.
- MetLife Investment Management held 14,459 shares of V2X worth $990K as of Q1 2026.
- MetLife Investment Management bought 1,678 V2X shares in Q1 2026, an estimated $113K.
- V2X made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1398 holding.
- MetLife Investment Management first reported a position in V2X in Q4 2017 and has held it in 34 quarters since.
- 295 funds tracked by Wall St. Rank held V2X as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.